Topic Highlight
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 7, 2008; 14(17): 2650-2661
Published online May 7, 2008. doi: 10.3748/wjg.14.2650
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 QUOROM flow diagram of included and excluded studies of probiotics for the treatment of Irritable Bowel Syndrome.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Number of randomized patients in 20 randomized, controlled clinical trials of probiotics for the treatment of Irritable Bowel Syndrome.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Forest Plot of randomized controlled trials of 14 treatment arms from 12 studies measuring relative risk of IBS symptoms after probiotic treatment compared to placebo. X-axis is relative risk, with black dot indicating the relative risk, line indicating 95% confidence interval and the size of the grey box proportional to sample size.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Funnel plots of randomized controlled trials for examining presence of IBS symptoms with probiotic or placebo treatments. RR: Relative risk of global IBS symptoms; s.e. of RR: Standard error of relative risk, an indicator of sample size.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Forest plot of randomized controlled trials of 12 treatment arms from 10 studies measuring relative risk of abdominal pain after treatment with a probiotic compared to placebo. The X-axis depicts relative risk, with black dot indicating the relative risk, line indicating 95% CI and the size of the grey box proportional to sample size.